Suzanne L Pollard1, John J Lima2, Edward Mougey2, Karina Romero3, Carla Tarazona-Meza4, Katherine Tomaino5, Gary Malpartida Guzmán4, Nadia N Hansel3, William Checkley6. 1. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 2. Center for Pharmacogenomics and Translational Research, Nemours Children's Health System, Jacksonville, Florida. 3. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland. 4. Biomedical Research Unit, AB PRISMA, Lima, Peru. 5. Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 6. Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. Electronic address: wcheckl1@jhmi.edu.
Abstract
BACKGROUND: Evidence suggests free mono-hydroxyvitamin D (25[OH]D) concentrations are more strongly linked to certain outcomes than total concentrations; however, no studies have examined the relation between free 25(OH)D and respiratory or allergic disease. OBJECTIVE: To examine associations between total and free 25(OH)D concentrations and asthma outcomes. METHODS: We quantified total and free 25(OH)D concentrations in 137 Peruvian children with asthma and 152 children without asthma and examined associations with asthma outcomes. RESULTS: Mean age ± SD was 13 ± 2.5 years, and 50.2% were boys. Mean total and measured free 25(OH)D concentrations were 29 ± 9.5 ng/mL and 5.0 ± 1.3 pg/mL, respectively. Lower free but not total 25(OH)D concentrations were significantly associated with atopy in all children (total, odds ratio [OR] 1.3 per 10-ng/mL decrease, 95% confidence interval [CI] 0.95-1.7, P = .12; vs free, OR 1.3 per 1-pg/mL decrease, 95% CI 1.0-1.6, P = .02) and children with asthma (total, OR 1.1 per 10-ng/mL decrease, 95% CI 0.75-1.7, P = .57; vs free, OR 1.6 per 1-pg/mL decrease, 95% CI 1.0-2.5, P = .04). Free but not total 25(OH)D levels were significantly associated with pre-bronchodilator forced expiratory volume in 1 second (total, 0.11 L, -0.12 to 0.34, P = .34; vs free, 0.20 L, 0.021-0.39, P = .03) and forced vital capacity (total, 0.13 L, -0.12 to 0.37, P = .31; vs free, 0.22 L, 0.026-0.42, P = .03) Z-scores in children with asthma. CONCLUSION: Atopy, forced expiratory volume in 1 second, and forced vital capacity were more strongly linked to free than to total 25(OH)D concentrations, suggesting the free form might be more relevant in modulating allergic disease risk and pulmonary function in children with asthma.
BACKGROUND: Evidence suggests free mono-hydroxyvitamin D (25[OH]D) concentrations are more strongly linked to certain outcomes than total concentrations; however, no studies have examined the relation between free 25(OH)D and respiratory or allergic disease. OBJECTIVE: To examine associations between total and free 25(OH)D concentrations and asthma outcomes. METHODS: We quantified total and free 25(OH)D concentrations in 137 Peruvian children with asthma and 152 children without asthma and examined associations with asthma outcomes. RESULTS: Mean age ± SD was 13 ± 2.5 years, and 50.2% were boys. Mean total and measured free 25(OH)D concentrations were 29 ± 9.5 ng/mL and 5.0 ± 1.3 pg/mL, respectively. Lower free but not total 25(OH)D concentrations were significantly associated with atopy in all children (total, odds ratio [OR] 1.3 per 10-ng/mL decrease, 95% confidence interval [CI] 0.95-1.7, P = .12; vs free, OR 1.3 per 1-pg/mL decrease, 95% CI 1.0-1.6, P = .02) and children with asthma (total, OR 1.1 per 10-ng/mL decrease, 95% CI 0.75-1.7, P = .57; vs free, OR 1.6 per 1-pg/mL decrease, 95% CI 1.0-2.5, P = .04). Free but not total 25(OH)D levels were significantly associated with pre-bronchodilator forced expiratory volume in 1 second (total, 0.11 L, -0.12 to 0.34, P = .34; vs free, 0.20 L, 0.021-0.39, P = .03) and forced vital capacity (total, 0.13 L, -0.12 to 0.37, P = .31; vs free, 0.22 L, 0.026-0.42, P = .03) Z-scores in children with asthma. CONCLUSION:Atopy, forced expiratory volume in 1 second, and forced vital capacity were more strongly linked to free than to total 25(OH)D concentrations, suggesting the free form might be more relevant in modulating allergic disease risk and pulmonary function in children with asthma.
Authors: Camille E Powe; Michele K Evans; Julia Wenger; Alan B Zonderman; Anders H Berg; Michael Nalls; Hector Tamez; Dongsheng Zhang; Ishir Bhan; S Ananth Karumanchi; Neil R Powe; Ravi Thadhani Journal: N Engl J Med Date: 2013-11-21 Impact factor: 91.245
Authors: Michael Schatz; Mark Kosinski; Aaron S Yarlas; Jennifer Hanlon; Maria E Watson; Priti Jhingran Journal: J Allergy Clin Immunol Date: 2009-09-19 Impact factor: 10.793
Authors: Ishir Bhan; Camille E Powe; Anders H Berg; Elizabeth Ankers; Julia B Wenger; S Ananth Karumanchi; Ravi I Thadhani Journal: Kidney Int Date: 2012-03-07 Impact factor: 10.612
Authors: Sonali Bose; Gregory B Diette; Han Woo; Kirsten Koehler; Karina Romero; Ana M Rule; Barbara Detrick; Emily Brigham; Meredith C McCormack; Nadia N Hansel Journal: J Allergy Clin Immunol Pract Date: 2019-02-11
Authors: Andrew Nicholson; Suzanne L Pollard; John J Lima; Karina M Romero; Carla Tarazona-Meza; Gary Malpartida-Guzmán; Edward Mougey; Nadia N Hansel; William Checkley Journal: Respir Med Date: 2017-11-03 Impact factor: 3.415
Authors: John J Lima; Mario Castro; Tonya S King; Jason E Lang; Victor E Ortega; Stephen P Peters; Loren C Denlinger; Elliot Israel; Christine A Sorkness; Michael E Wechsler; Sally E Wenzel; Lewis J Smith Journal: Ann Allergy Asthma Immunol Date: 2018-06-14 Impact factor: 6.347